The Latest Breaking News on Pharma

Germany's vaccine advisory panel on Thursday recommended that Pfizer-BioNTech's COVID-19 vaccine for children from six months to four years should only be given routinely to those at risk of severe disease from the infection.

Infections from some antibiotic-resistant pathogens known as superbugs have more than doubled in health care facilities in Europe, an EU agency said on Thursday, providing further evidence of the wider impact of the COVID-19 pandemic.

People taking the painkiller could be more likely to take risks

A Relative Strength Rating upgrade for Moderna shows improving technical performance.

Chinese President Xi Jinping and Indonesian President Joko Widodo held formal talks on Wednesday on the Indonesian island of Bali, with both leaders pledging closer cooperation on the development of COVID-19 vaccines.

With fears of an impending recession weighing on investment decisions and driving market volatility, blue-chip stocks could be smart picks. Shares of well-reputed companies AbbVie (ABBV), Honeywell International (HON), and Lockheed Martin (LMT) could help safeguard investors’ portfolios against market volatility through their fundamental strength and stable dividends. Continue reading….

The three illnesses can be dangerous for expectant mums and their babies, warns the NHS

A cooling down inflation has instilled optimism among investors, and experts now see a possibility of a soft landing of the economy. Hence, it could be wise to invest in fundamentally solid and dividend-paying stocks Merck & Co. (MRK) and Gilead Sciences (GILD), which look poised to deliver steady gains.…

WASHINGTON — After two winters spent masked and 6 feet apart, pediatric respiratory viruses have returned with a vengeance, and pediatric hospitals, emergency room doctors and pediatricians are lobbying Congress and the Biden administration to provide more support.